Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.
Clinical trial NCT03212716 · TERMINATED
Trial details
- NCT number
- NCT03212716
- Sponsor
- University Hospital, Lille
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-23
- Primary completion
- 2022-05-04
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.